Laura Menditto

461 total citations
12 papers, 320 citations indexed

About

Laura Menditto is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Laura Menditto has authored 12 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Laura Menditto's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (5 papers) and Anesthesia and Pain Management (2 papers). Laura Menditto is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (5 papers) and Anesthesia and Pain Management (2 papers). Laura Menditto collaborates with scholars based in United States, Canada and United Kingdom. Laura Menditto's co-authors include Margaret Good, Amin Haiderali, April Teitelbaum, Michael Bullano, Maxine D. Fisher, Vincent J. Willey, Quanwu Zhang, Ibrahim Al‐Zakwani, Karen Wells and Susan A. Oliveria and has published in prestigious journals such as Supportive Care in Cancer, Current Medical Research and Opinion and American Journal of Health-System Pharmacy.

In The Last Decade

Laura Menditto

12 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Menditto United States 9 159 134 50 48 27 12 320
Harn-Shen Chen Taiwan 11 217 1.4× 71 0.5× 33 0.7× 43 0.9× 56 2.1× 30 390
Winston Crasto United Kingdom 8 201 1.3× 66 0.5× 45 0.9× 50 1.0× 24 0.9× 18 318
A Antonino Italy 8 74 0.5× 267 2.0× 50 1.0× 7 0.1× 21 0.8× 15 353
Elizabeth W. Duggan United States 8 274 1.7× 209 1.6× 43 0.9× 34 0.7× 188 7.0× 25 443
Beatrice Vigo Italy 8 92 0.6× 42 0.3× 94 1.9× 36 0.8× 46 1.7× 14 325
Andreas Liebl Germany 10 426 2.7× 93 0.7× 55 1.1× 33 0.7× 13 0.5× 17 509
Lene Ring Madsen Denmark 10 84 0.5× 172 1.3× 88 1.8× 27 0.6× 13 0.5× 21 316
Chiara Veronesi Italy 10 80 0.5× 105 0.8× 15 0.3× 27 0.6× 102 3.8× 52 335
Jorge Dores Portugal 11 102 0.6× 109 0.8× 49 1.0× 29 0.6× 28 1.0× 43 330
Maurizio Giacomelli Italy 8 57 0.4× 218 1.6× 140 2.8× 13 0.3× 74 2.7× 12 393

Countries citing papers authored by Laura Menditto

Since Specialization
Citations

This map shows the geographic impact of Laura Menditto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Menditto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Menditto more than expected).

Fields of papers citing papers by Laura Menditto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Menditto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Menditto. The network helps show where Laura Menditto may publish in the future.

Co-authorship network of co-authors of Laura Menditto

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Menditto. A scholar is included among the top collaborators of Laura Menditto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Menditto. Laura Menditto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Minkowitz, Harold S., et al.. (2014). Development and Validation of a Risk Score to Identify Patients at High Risk for Opioid-Related Adverse Drug Events. Journal of Managed Care Pharmacy. 20(9). 948–958. 21 indexed citations
2.
Changolkar, Arun, et al.. (2014). Comparison of injectable anticoagulants for thromboprophylaxis after cancer-related surgery. American Journal of Health-System Pharmacy. 71(7). 562–569. 7 indexed citations
3.
Lafeuille, Marie‐Hélène, et al.. (2012). Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 53(6). 1146–1154. 13 indexed citations
4.
Haiderali, Amin, et al.. (2010). Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US population. Supportive Care in Cancer. 19(6). 843–851. 95 indexed citations
5.
Weissman, Peter N., et al.. (2009). Clinical Practice Effect of Rosiglitazone Discontinuation on Glycemic Control. Endocrine Practice. 15(3). 270–272. 4 indexed citations
6.
Happe, Laura E., et al.. (2008). Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants. Current Medical Research and Opinion. 25(2). 413–420. 17 indexed citations
7.
Oliveria, Susan A., et al.. (2007). Barriers to the initiation of, and persistence with, insulin therapy. Current Medical Research and Opinion. 23(12). 3105–3112. 41 indexed citations
8.
Bullano, Michael, et al.. (2006). Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products. American Journal of Health-System Pharmacy. 63(24). 2473–2482. 22 indexed citations
9.
Zhang, Quanwu & Laura Menditto. (2005). Incremental Cost Savings 6 Months Following Initiation of Insulin Glargine in a Medicaid Fee-For-Service Sample. American Journal of Therapeutics. 12(4). 337–343. 22 indexed citations
10.
Bullano, Michael, Ibrahim Al‐Zakwani, Maxine D. Fisher, Laura Menditto, & Vincent J. Willey. (2005). Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products. Current Medical Research and Opinion. 21(2). 291–298. 50 indexed citations
11.
Garg, Satish K., et al.. (2004). Reduced Severe Hypoglycemia with Insulin Glargine in Intensively Treated Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 6(5). 589–595. 27 indexed citations
12.
Menditto, Laura, et al.. (1993). A surgical alternative in the management of chronic neurotrophic ulcerations of the foot.. PubMed. 32(3). 295–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harn-Shen Chen Breakdown of academic impact, for papers by Winston Crasto Breakdown of academic impact, for papers by A Antonino Breakdown of academic impact, for papers by Elizabeth W. Duggan Breakdown of academic impact, for papers by Beatrice Vigo Breakdown of academic impact, for papers by Andreas Liebl Breakdown of academic impact, for papers by Lene Ring Madsen Breakdown of academic impact, for papers by Chiara Veronesi Breakdown of academic impact, for papers by Jorge Dores Breakdown of academic impact, for papers by Maurizio Giacomelli
Rankless by CCL
2026